Correlation of bevacizumab-induced hypertension and outcome in the BOXER study, a phase II study of capecitabine, oxaliplatin (CAPOX) plus bevacizumab as peri-operative treatment i...

por Dewdney, A, Cunningham, D, Barbachano, Y, Chau, I
Publicado 2012

Sequential induction chemotherapy followed by radical chemo-radiation in the treatment of locoregionally advanced head-and-neck cancer

por Bhide, S A, Ahmed, M, Barbachano, Y, Newbold, K, Harrington, K J, Nutting, C M
Publicado 2008

Preoperative computed tomography staging of nonmetastatic colon cancer predicts outcome: implications for clinical trials

por Smith, N J, Bees, N, Barbachano, Y, Norman, A R, Swift, R I, Brown, G
Publicado 2007

Toxicity associated with capecitabine plus oxaliplatin in colorectal cancer before and after an institutional policy of capecitabine dose reduction

por Baird, R, Biondo, A, Chhaya, V, McLachlan, J, Karpathakis, A, Rahman, S, Barbachano, Y, Cunningham, D, Chau, I
Publicado 2011

The Prevalence of Pain in Patients Attending Sarcoma Outpatient Clinics

por Kuo, P. Y., Yen, J. T. C., Parker, G. M., Chapman, S., Kandikattu, S., Sohanpal, I., Barbachano, Y., Williams, J. E.
Publicado 2011

Expression of CC chemokine receptor 7 in tonsillar cancer predicts cervical nodal metastasis, systemic relapse and survival

por Pitkin, L, Luangdilok, S, Corbishley, C, Wilson, P O G, Dalton, P, Bray, D, Mady, S, Williamson, P, Odutoye, T, Rhys Evans, P, Syrigos, K N, Nutting, C M, Barbachano, Y, Eccles, S, Harrington, K J
Publicado 2007

Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis

por Edwards, S M, Evans, D G R, Hope, Q, Norman, A R, Barbachano, Y, Bullock, S, Kote-Jarai, Z, Meitz, J, Falconer, A, Osin, P, Fisher, C, Guy, M, Jhavar, S G, Hall, A L, O'Brien, L T, Gehr-Swain, B N, Wilkinson, R A, Forrest, M S, Dearnaley, D P, Ardern-Jones, A T, Page, E C, Easton, D F, Eeles, R A
Publicado 2010